Genetic Technologies (GENE) has released an update.
Genetic Technologies Limited is expanding its financial horizons with a U.S. capital-raising venture offering 560,000 American Depositary Shares (ADS) and additional pre-funded warrants. Investors are set to gain access to 30 ordinary shares per ADS, with the company expecting to raise approximately $1,120,000 through the ADS sales and around $879,560 through the warrants. This strategic move, managed by H.C. Wainwright & Co., aims to engage U.S. investors and strengthen the company’s financial position.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.
